0.6229
Dariohealth Corp Stock (DRIO) Latest News
DarioHealth Corp Inc. (DRIO) Price Performance: The Role of Volume and Liquidity - The InvestChronicle
DarioHealth Corp (DRIO)’s stock price range in the last year - US Post News
DarioHealth adds new Blue Cross Blue Shield to payer network - MSN
DarioHealth Corp (DRIO) rating downgrades by TD Cowen - Knox Daily
DarioHealth stock hits 52-week low at $0.63 amid market challenges - MSN
DarioHealth Corp. (DRIO) Expands Health Plan Reach with New Blue Cross Blue Shield Agreement - Insider Monkey
How does DRIO’s price to cash per share ratio compare in the market? - US Post News
Market News Alert: DarioHealth Secures Significant New Agreement, Expanding Growth in the $1.2 Trillion Dollar Cardiometabolic Market - sharewise
DarioHealth Gains on Deal with Blue Cross - Baystreet.ca
Market News Alert: DarioHealth Secures Significant New Agreement, Expanding Growth in the $1.2 Trillion Dollar Cardiometabolic Market | FinancialContent Business Page - Financial Content
DarioHealth inks deal with Blue Cross Blue Shield By Investing.com - Investing.com Nigeria
DarioHealth inks deal with Blue Cross Blue Shield - MSN
DarioHealth Expands Digital Health Empire with Landmark BCBS DealAI Platform Set to Transform $1.2T Market - StockTitan
Comparing DarioHealth (NASDAQ:DRIO) and PROCEPT BioRobotics (NASDAQ:PRCT) - Defense World
DarioHealth (NASDAQ:DRIO) Stock Rating Lowered by TD Cowen - Defense World
PESG Report: DarioHealth Positions Itself as a Market Leader in the Multi-Billion-Dollar Digital Health Transformation - Business Wire
TD Cowen cuts DarioHealth stock rating amid growth concerns - MSN
TD Cowen Downgrades DarioHealth to Hold From Buy, Adjusts Price Target to $1 From $2 - Marketscreener.com
DarioHealth Corp. Secures $25.6 Million Private Placement to Support Strategic Operational Objectives - Defense World
All You Need to Know About DarioHealth (DRIO) Rating Upgrade to Strong Buy - MSN
DarioHealth Announces $25.6M Private Placement Positioning the Company to Execute on Strategy Aiming to Reach Operational Cash Flow Positive Run Rate by the End of 2025 - PR Newswire
Contrasting Nyxoah (NASDAQ:NYXH) and DarioHealth (NASDAQ:DRIO) - Defense World
DarioHealth Corp (DRIO): AI Solutions for Health and Wellness - Insider Monkey
DRIODarioHealth Corp. Latest Stock News & Market Updates - StockTitan
DarioHealth Expands Weight Loss Platform With GLP-1 Prescriptions as Stock Surges 14% - StockTitan
DarioHealth Expands GLP-1 Solution with Prescribing Capabilities through Collaboration with MediOrbis, Targeting Employers and Direct-to-Consumer Markets - WV News
DarioHealth Expands GLP-1 Weight-Loss Solution, Unlocking New Revenue Streams in Rapidly Growing Multi Billion Dollar Market - Marketscreener.com
DarioHealth Corp. announced that it expects to receive $6.824 million in funding -January 06, 2025 - Marketscreener.com
DarioHealth Corp. (NASDAQ:DRIO) Short Interest Update - Defense World
DarioHealth stock hits 52-week low at $0.64 amid market challenges - Investing.com
DarioHealth Stock Hits 52-Week Low at $0.66 Amid Market Challenges By Investing.com - Investing.com South Africa
DarioHealth Stock Hits 52-Week Low at $0.66 Amid Market Challenges - Investing.com Canada
DarioHealth Corp confirms new board, ratifies auditors - Investing.com India
DarioHealth Corp confirms new board, ratifies auditors By Investing.com - Investing.com UK
Dario Signs Four New Employer Contracts Across Full Product Suite - The Eastern Progress Online
DarioHealth Stock Hits 52-Week Low at $0.67 Amid Market Challenges - Investing.com Canada
DarioHealth Stock Hits 52-Week Low at $0.67 Amid Market Challenges By Investing.com - Investing.com South Africa
Dario Announces Complete Integration of Twill Capabilities Across Full Multi-Condition Platform - The Eastern Progress Online
DarioHealth Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
DarioHealth stock hits 52-week low at $0.7 amid market challenges - Investing.com Canada
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):